glp-1 and type 1 diabetes vs. GLP-1 + GIP: What's the Difference for your Metabolism? GLP-1s for Type 1s -

In the New England Journal of Medicine, Garvey and colleagues [5] report the results of the REDEFINE 1 trial, a 68-week, phase 3a double-blind, placebo-controlled and active-controlled trial evaluating the efficacy and safety of coadministered cagrilintide and semaglutide in adults with obesity [body mass index (BMI) 30 kg/m 2 ] or overweight (BMI 27 kg/m 2 ) with at least one weight-related comorbidity

The early appearance of GT in neoplasms suggests the potential for GT to play a role in tumor progression

The individual peptides in this set have been investigated in preclinical and cell-based laboratory research across several distinct signalling pathways

Sharp pain, pain that worsens progressively, or pain accompanied by fever could indicate pancreatitisa known rare adverse effect of GLP-1 medicationsor other acute abdominal conditions

For more on how gut health connects to immunity, see our article on how to improve gut health

& Eldar-Finkelman, H